Department of Pharmacy, Banasthali Vidyapith, Tonk, Rajasthan, India.
Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India.
Pharm Nanotechnol. 2024;12(3):185-196. doi: 10.2174/2211738511666230818125031.
Among the various prominent fungal infections, superficial ones are widespread. A large number of antifungal agents and their formulations for topical use are commercially available. They have some pharmacokinetic limitations which cannot be retracted by conventional delivery systems. While nanoformulations composed of lipidic and polymeric nanoparticles have the potential to overcome the limitations of conventional systems. The broad spectrum category of antifungals i.e. azoles (ketoconazole, voriconazole, econazole, miconazole, etc.) nanoparticles have been designed, prepared and their pharmacokinetic and pharmacodynamic profile was established. This review briefly elaborates on the types of nano-based topical drug delivery systems and portrays their advantages for researchers in the related field to benefit the available antifungal therapeutics.
在各种突出的真菌感染中,浅表性真菌感染较为常见。大量的抗真菌药物及其局部用制剂可在商业上获得。它们具有一些不能通过常规传递系统收回的药代动力学限制。而由脂质和聚合物纳米颗粒组成的纳米制剂有可能克服常规系统的局限性。广谱抗真菌药物,即唑类(酮康唑、伏立康唑、益康唑、咪康唑等)纳米颗粒已经被设计、制备,并确定了它们的药代动力学和药效学特征。这篇综述简要阐述了基于纳米的局部药物传递系统的类型,并描述了它们对相关领域研究人员的优势,以有益于现有的抗真菌治疗。